N-acetylcysteine Effects on Tetrahydrocannabinol



Status:Active, not recruiting
Conditions:Healthy Studies
Therapuetic Areas:Other
Healthy:No
Age Range:18 - 55
Updated:6/8/2018
Start Date:March 2014
End Date:January 2019

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Effect of N-acetylcysteine on the Acute Cognitive Effects of Delta-9-Tetrahydrocannabinol

The overall purpose of this study is to examine the effect of N-acetylcysteine (NAC) on the
acute effects of Delta-9-tetrahydrocannabinol (THC). This will be tested by pretreating
healthy individuals with NAC and then assessing their responses to THC.


Inclusion Criteria:

- Exposed to Cannabis at least once in lifetime

Exclusion Criteria:

- Cannabis Naive

- Individuals with a documented allergy to N-acetylcysteine
We found this trial at
1
site
VA Connecticut Healthcare System
950 Campbell Ave
West Haven, Connecticut 06516
(203) 932-5711
Principal Investigator: Mohini Ranganathan, MD
Phone: 203-932-5711
VA Connecticut Healthcare System VA Connecticut encompasses an inpatient facility and Ambulatory Care Center in...
?
mi
from
West Haven, CT
Click here to add this to my saved trials